Cyprumed announces the appointment of Martin E. Judge as Chief Business Officer, effective immediately.
With deep experience in pharma/biotech licensing, strategy and establishment of partnerships, Martin will play a key role in advancing our mission and executing our strategy. He has a background in life sciences and technologies in areas relevant to the Pharma industry based on his education (PhD in Basic Medical Sciences, New York University) and professional experience in R&D and Business Development at Novo Nordisk.
Welcome to the team!